Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its latest quarterly report later this week. Experts are expecting strong results driven by the continued success of Lilly's blockbuster drugs, particularly recent launches. However, there are also concerns about potential challenges from regula